We need a temporary moratorium on using gene editing to create babies
By Paul Knoepfler,
STAT
| 12. 03. 2018
The rationales for human germline editing don’t make much sense to me. They consist of invoking rare or even hypothetical scenarios where CRISPR might serve some purpose that cannot be achieved by already proven and safe embryo screening methods such as pre-implantation genetic diagnosis.
On a cold, drizzly night almost three years ago, I stood inside the nearly deserted Lincoln Memorial in Washington, D.C., I was in town to attend the first International Summit on Human Gene Editing organized by the National Academy of Sciences and the National Academy of Medicine. After a day of intense talks at the meeting, I had gone for a long walk and found myself looking up at Big Abe. A big question was on my mind: Would the organizers of the meeting call for a moratorium on using CRISPR to make gene-edited babies, as I hoped they would?
They didn’t.
When I learned of that decision, my feeling was that someone would report the creation of the first “CRISPR baby” within the next few years. That might happen even with a moratorium, but the odds had just increased substantially.
Since then, there have been similar meetings around the world about human germline gene editing — editing eggs, sperm, and embryos that are then used to make people — along with official reports from committees. None called for a...
Related Articles
By Pallab Gosh and Gwyndaf Hughes, BBC News | 06.26.2025
Work has begun on a controversial project to create the building blocks of human life from scratch, in what is believed to be a world first.
The research has been taboo until now because of concerns it could lead to...
By Rhys Blakely, The Times | 06.24.2025
Scientists have created fertile mice from male genetic material alone, a breakthrough that could one day open the door to human babies who inherit their genes from two fathers.
The experiment, led by Professor Yanchang Wei at Shanghai Jiao Tong...
By Gina Kolata, The New York Times | 06.20.2025
A single infusion of a stem cell-based treatment may have cured 10 out of 12 people with the most severe form of type 1 diabetes. One year later, these 10 patients no longer need insulin. The other two patients need...